MedTrace Logo

A Study to Evaluate the BrainPort® Vision Device in Subjects Who Are Blind

NCT01488786 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2013-08-09

No results posted yet for this study

Summary

The purpose of this study is to assess the safety of the BrainPort vision device and to demonstrate improved object recognition and word identification and ambulation with use of the BrainPort vision device in subjects who are medically documented as blind, with acuity of 20/ 5000 or worse.

Conditions

Interventions

DEVICE

BrainPort Vision Device

2-3 days of training (10 hours) followed by minimum in-home use 300 minutes per month for 12 months.

Sponsors & Collaborators

  • Wicab

    lead INDUSTRY

Principal Investigators

  • Aimee Arnoldussen · Wicab, Inc.

  • William Seiple · Lighthouse International

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01488786 on ClinicalTrials.gov